Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Oct;19(5 Suppl 6):30-5.

Biopharmaceutical aspects of FK-506

Affiliations

Biopharmaceutical aspects of FK-506

R Venkataramanan et al. Transplant Proc. 1987 Oct.

Abstract

FK is a potent immunosuppressive agent. FK can be analyzed in biologic fluids by EIA. The oral absorption of FK is rapid but variable in dogs. After intramuscular administration, FK is slowly and continuously absorbed. FK is primarily eliminated by metabolism. Less than 1% of the administered dose is excreted in the bile or the urine. After chronic intramuscular administration FK inhibits drug metabolism. Monitoring of FK levels in plasma is essential for the proper interpretation of efficacy and toxicity studies.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Chemical structure of FK-506.
Fig 2
Fig 2
Standard curve of plasma FK concentration v optical density at 492 nm.
Fig 3
Fig 3
Plasma concentration of FK in a dog (no. 2) on day 8 aftar daily oral administration of 1 mg/kg of FK.
Fig 4
Fig 4
Plasma concentration of FK in a dog. (no. 3) on day 8 aftar daily oral administration of 1 mg/kg of FK.
Fig 5
Fig 5
Area under tha plasma FK concentration–-v-time curve after oral administration of 1, 2, and 4 mg/kg of FK.
Fig 6
Fig 6
Plasma concentration of FK in dog no. 10(Δ) and dog no. 11 (O) after a single intramuscular injection of 0.49 mg/kg of FK.

References

    1. Zeevi A. Transplant Proc. this issue.
    1. Todo S. Transplant Proc. this issue.
    1. Todo S. Transplant Proc. this issue.
    1. Todo S. Transplant Proc. this issue.
    1. Ericzon BG, Todo S, Lynch S, et al. Transplant Proc. 1987;19:1248. - PMC - PubMed

MeSH terms

LinkOut - more resources